We would explore whether MALAT1, miR‐185‐5p and the RhoA/ROCK pathway play a role in HG‐induced mitochondrial damage and cardiomyocyte apoptosis, with the aim of providing a novel therapeutic target for DCM. The gene discussed is RHOA; the disease is familial dilated cardiomyopathy.